Skip to main content
Top

Esophagus

Issue 1/2014

Content (6 Articles)

Special Article

Comprehensive Registry of Esophageal Cancer in Japan, 2005

Yuji Tachimori, Soji Ozawa, Mitsuhiro Fujishiro, Hisahiro Matsubara, Hodaka Numasaki, Tsuneo Oyama, Masayuki Shinoda, Yasushi Toh, Harushi Udagawa, Takashi Uno

Special Article

Comprehensive Registry of Esophageal Cancer in Japan, 2006

Yuji Tachimori, Soji Ozawa, Mitsuhiro Fujishiro, Hisahiro Matsubara, Hodaka Numasaki, Tsuneo Oyama, Masayuki Shinoda, Yasushi Toh, Harushi Udagawa, Takashi Uno

Original Article

Expression analysis of fibroblast growth factor receptor-like 1 (FGFRL1) in esophageal squamous cell carcinoma

Yutaka Shimada, Tomoyuki Okumura, Takuya Nagata, Isaya Hashimoto, Shigeaki Sawada, Toru Yoshida, Junya Fukuoka, Kazuharu Shimizu, Kazuhiro Tsukada

Original Article

Surgical treatment for Zenker’s diverticulum: comparison between diverticulectomy and diverticulopexy

Francesco Puma, Jacopo Vannucci, Claudio Fioroni, Elisa Scarnecchia, Verena De Angelis, Nicola Avenia, Mark Ragusa, Giuliano Daddi

Original Article

Tumor blood flow change measured by CT perfusion during chemoradiation therapy (CRT) for monitoring response and predicting survival in patients with esophageal cancer

Koichi Hayano, Kiyohiko Shuto, Asami Satoh, Tomoyoshi Aoyagi, Kazuo Narushima, Hisashi Gunji, Tsuguaki Kono, Noriyuki Yanagawa, Shinichi Okazumi, Hisahiro Matsubara

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine